Related Experiment Video
Updated: Aug 19, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
[HELLP syndrome]
P Emonts1, H Thoumsin, J M Foidart
1Service de Gynécologie-Obstétrique, Université de Liège.
Abstract:
The HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelet count) is a clinical expression of a multilayered disease whose central pathophysiology is abnormal placentation. Clinical research aims logically to search for new predictive and specific markers for the early identification of pregnant women at risk of developing a HELLP syndrome, the most common cause of feto-maternal mortality and morbidity.
Related Concept Videos
Heart Failure III: Clinical Manifestations
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cushing Syndrome II: Pathophysiology
Gastritis II: Pathophysiology
Portal Hypertension
Hepatic Encephalopathy

